1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AUROBINDO PHARMA LTD.
Aurobindo Pharma Ltd.
NSE: AUROPHARMA | BSE: 524804
Strong Performer, Getting Expensive
In 4 Starfolio Baskets
Download real time
Iran War Impact
1462.30 -1.30 (-0.09%)
43.91% Gain from 52W Low
1.4M
NSE+BSE Volume

NSE 05 Jun, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Aurobindo Pharma gets US FDA nod for an autoimmune disease treatment, with a market size of $494 mn See details

Aurobindo Pharma Delivery Percentage and Volume Analysis for NSE and BSE as of 07 Jun, 2026

Aurobindo Pharma Delivery Traded Volume, Percentages, Week Average and Analysis for NSE and BSE as of 07 Jun, 2026

Delivery Stock Screeners